Defining the Optimal Selenium Dose for Prostate Cancer Risk Reduction: Insights from the U-Shaped Relationship Between Selenium Status, DNA Damage, and Apoptosis

Chiang, Emily C.; Shen, Shuren; Kengeri, Seema S.; Xu, Huiping; Combs, Gerald F.; Morris, J. Steven; Bostwick, David G.; Waters, David J.
July 2010
Dose-Response;2010, Vol. 8 Issue 3, p285
Academic Journal
Our work in dogs has revealed a U-shaped dose response between selenium status and prostatic DNA damage that remarkably parallels the relationship between dietary selenium and prostate cancer risk in men, suggesting that more selenium is not necessarily better. Herein, we extend this canine work to show that the selenium dose that minimizes prostatic DNA damage also maximizes apoptosis-a cancer-suppressing death switch used by prostatic epithelial cells. These provocative findings suggest a new line of thinking about how selenium can reduce cancer risk. Mid-range selenium status (.67-.92 ppm in toenails) favors a process we call "homeostatic housecleaning"-an upregulated apoptosis that preferentially purges damaged prostatic cells. Also, the U-shaped relationship provides valuable insight into stratifying individuals as selenium-responsive or selenium-refractory, based upon the likelihood of reducing their cancer risk by additional selenium. By studying elderly dogs, the only non-human animal model of spontaneous prostate cancer, we have established a robust experimental approach bridging the gap between laboratory and human studies that can help to define the optimal doses of cancer preventives for large-scale human trials. Moreover, our observations bring much needed clarity to the null results of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) and set a new research priority: testing whether men with low, suboptimal selenium levels less than 0.8 ppm in toenails can achieve cancer risk reduction through daily supplementation.


Related Articles

  • Selenium may prevent prostate cancer. Osterweil, Neil // Urology Times;Feb97, Vol. 25 Issue 2, p1 

    Cites a study on the link between selenium intake and prostate cancer risk, conducted by Larry C. Clark and colleagues at the Arizona Cancer Center of the University of Arizona College of Medicine. Reduction in risk of developing prostate cancer among subjects who took selenium supplements;...

  • Selenium.  // Reactions Weekly;5/30/2009, Issue 1254, p37 

    The article describes the cases of a woman and her three children who experienced selenosis following consumption of a dietary supplement with selenium. The woman, who had a history of intermittent flu-like symptoms, was presented with severe myalgias, nausea, fatigue and anorexia. Her children...

  • Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders. Ling Zhang; Gang Wang; Jiong Luo; Qing-E Zhang; Qian Zhao; Qi-Ying Deng; Xin Ma // Neuropsychiatric Disease & Treatment;2013, Vol. 9, p575 

    Background: Although quetiapine has often been used as monotherapy or adjunctive therapy in bipolar disorder, there is very limited clinical evidence regarding prescribing practices for quetiapine as maintenance treatment for bipolar disorder. Methods: We reviewed the inpatient and outpatient...

  • HORMESIS: Principles and Applications for Pharmacology and Toxicology. Calabrese, Edward J. // American Journal of Pharmacology & Toxicology;2008, Vol. 3 Issue 1, p56 

    The present assessment places hormetic dose responses within an historical context, documenting its origin, rejection by the biomedical community during the early decades of the 20th due to its close association with homeopathy and its revitalization during the later decades of the past century...

  • Assessment of entrance surface dose and health risk from common radiology examinations in Iran. Shahbazi-Gahrouei, Daryoush; Baradaran-Ghahfarokhi, Milad // Radiation Protection Dosimetry;May2013, Vol. 154 Issue 3, p308 

    Medical X-ray exposures are the largest man-made source of population exposure to ionising radiation in many countries. Although information on medical exposure is already incorporated into national legislative documents, in Isfahan there is no data on the assessment of patient's entrance...

  • Injection-site Malignant Fibrous Histiocytomas in a Pegvisomant Carcinogenicity Study in SD Rats. Bartholomew, Phillip M.; Kreeger, John M.; Morton, Daniel // Toxicologic Pathology;Oct2014, Vol. 42 Issue 7, p1082 

    In a 2-year rat carcinogenicity study, pegvisomant injected subcutaneously on a daily basis at doses of 0, 2, 8, or 20 mg/kg/day produced malignant fibrous histiocytomas (MFHs) at the injection sites of 3 male rats (5%) given 8 mg/kg/day and 5 males (8%) given 20 mg/kg/day. MFH was characterized...

  • Redefining Low Lead Levels. Iavicoli, Ivo; Calabrese, Edward J. // Environmental Health Perspectives;May2011, Vol. 119 Issue 5, pA202 

    A letter to the editor is presented in response to the article "Low-level gestational lead exposure increases retinal progenitor cell proliferation and rod photoreceptor and bipolar cell neurogenesis in mice," by A. Giddabasappa and colleagues in the January 2011 issue.

  • A dose-response meta-analysis of dietary lutein and zeaxanthin intake in relation to risk of age-related cataract. Ma, Le; Hao, Zhen-xuan; Liu, Ru-ru; Yu, Rong-bin; Shi, Qiang; Pan, Jian-ping // Graefe's Archive of Clinical & Experimental Ophthalmology;Jan2014, Vol. 252 Issue 1, p63 

    Background: Lutein and zeaxanthin are thought to have beneficial effects on protecting the lens against cataract formation, but findings from epidemiologic studies have been inconsistent. We aimed to conduct a meta-analysis of prospective cohort studies to examine the association between dietary...

  • Selenium poisoning due to poor quality control. Gaby, Alan R. // Townsend Letter;Feb/Mar2009, Issue 307/308, p58 

    The article describes the case of a 55-year-old woman who developed selenosis after taking a liquid nutritional supplement. It references a study by M. E. Sutter et al, published in a 2008 issue of the "Annals of Internal Medicine." Noted side effects on the woman included a 6-week history of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics